Alteration of complement hemolytic activity in different trauma and sepsis models

Christian Ehrnthaller,1 Umme Amara,1 Sebastian Weckbach,1 Miriam Kalbitz,1 Markus Huber-Lang,1 Soheyl Bahrami21Department of Traumatology, Hand, Plastic, and Reconstructive Surgery, Center of Surgery, University of Ulm, Germany; 2Ludwig Boltzmann Institute for Experimental and Clinical Traumatology,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ehrnthaller C, Amara U, Weckbach S, Kalbitz M, Huber-Lang M, Bahrami S
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://doaj.org/article/59d5545deedf4656bb2db3b57c0213fa
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:59d5545deedf4656bb2db3b57c0213fa
record_format dspace
spelling oai:doaj.org-article:59d5545deedf4656bb2db3b57c0213fa2021-12-02T01:25:33ZAlteration of complement hemolytic activity in different trauma and sepsis models1178-7031https://doaj.org/article/59d5545deedf4656bb2db3b57c0213fa2012-07-01T00:00:00Zhttp://www.dovepress.com/alteration-of-complement-hemolytic-activity-in-different-trauma-and-se-a10540https://doaj.org/toc/1178-7031Christian Ehrnthaller,1 Umme Amara,1 Sebastian Weckbach,1 Miriam Kalbitz,1 Markus Huber-Lang,1 Soheyl Bahrami21Department of Traumatology, Hand, Plastic, and Reconstructive Surgery, Center of Surgery, University of Ulm, Germany; 2Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, AustriaAbstract: Complement activation is involved in various diseases in which innate immunity plays a crucial role. However, its pathophysiological relevance is not clearly understood. Experimental models have been widely used to characterize the role of complement activation under different pathological conditions, such as hypoxemia, ischemia and reperfusion, tissue damage, and polymicrobial invasion. Screening of the complement status and function is, however, strongly dependent on the laboratory-specific techniques being used to sample and measure complement, making it difficult to compare the results found in different laboratories. Therefore, we evaluated complement function by measuring complement hemolytic activity (CH50) in various animal models of isolated ischemia reperfusion (I/R: kidney, liver, gut), hemorrhagic traumatic shock (HTS), endotoxic shock (LPS), and sepsis (CLP). Complement activation was less pronounced in isolated models of ischemia and reperfusion, whereas a strong complement response was observed early after HTS, CLP, and LPS. In summary, CH50 is a well-established, quick, and cost-effective screening method of complement function. However, because we obtained different results in clinically relevant animal models, further differentiation using specific complement factor analysis is necessary.Keywords: CH50, complement, hemorrhagic shock, inflammation, ischemia/reperfusion, sepsisEhrnthaller CAmara UWeckbach SKalbitz MHuber-Lang MBahrami SDove Medical PressarticlePathologyRB1-214Therapeutics. PharmacologyRM1-950ENJournal of Inflammation Research, Vol 2012, Iss default, Pp 59-66 (2012)
institution DOAJ
collection DOAJ
language EN
topic Pathology
RB1-214
Therapeutics. Pharmacology
RM1-950
spellingShingle Pathology
RB1-214
Therapeutics. Pharmacology
RM1-950
Ehrnthaller C
Amara U
Weckbach S
Kalbitz M
Huber-Lang M
Bahrami S
Alteration of complement hemolytic activity in different trauma and sepsis models
description Christian Ehrnthaller,1 Umme Amara,1 Sebastian Weckbach,1 Miriam Kalbitz,1 Markus Huber-Lang,1 Soheyl Bahrami21Department of Traumatology, Hand, Plastic, and Reconstructive Surgery, Center of Surgery, University of Ulm, Germany; 2Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, AustriaAbstract: Complement activation is involved in various diseases in which innate immunity plays a crucial role. However, its pathophysiological relevance is not clearly understood. Experimental models have been widely used to characterize the role of complement activation under different pathological conditions, such as hypoxemia, ischemia and reperfusion, tissue damage, and polymicrobial invasion. Screening of the complement status and function is, however, strongly dependent on the laboratory-specific techniques being used to sample and measure complement, making it difficult to compare the results found in different laboratories. Therefore, we evaluated complement function by measuring complement hemolytic activity (CH50) in various animal models of isolated ischemia reperfusion (I/R: kidney, liver, gut), hemorrhagic traumatic shock (HTS), endotoxic shock (LPS), and sepsis (CLP). Complement activation was less pronounced in isolated models of ischemia and reperfusion, whereas a strong complement response was observed early after HTS, CLP, and LPS. In summary, CH50 is a well-established, quick, and cost-effective screening method of complement function. However, because we obtained different results in clinically relevant animal models, further differentiation using specific complement factor analysis is necessary.Keywords: CH50, complement, hemorrhagic shock, inflammation, ischemia/reperfusion, sepsis
format article
author Ehrnthaller C
Amara U
Weckbach S
Kalbitz M
Huber-Lang M
Bahrami S
author_facet Ehrnthaller C
Amara U
Weckbach S
Kalbitz M
Huber-Lang M
Bahrami S
author_sort Ehrnthaller C
title Alteration of complement hemolytic activity in different trauma and sepsis models
title_short Alteration of complement hemolytic activity in different trauma and sepsis models
title_full Alteration of complement hemolytic activity in different trauma and sepsis models
title_fullStr Alteration of complement hemolytic activity in different trauma and sepsis models
title_full_unstemmed Alteration of complement hemolytic activity in different trauma and sepsis models
title_sort alteration of complement hemolytic activity in different trauma and sepsis models
publisher Dove Medical Press
publishDate 2012
url https://doaj.org/article/59d5545deedf4656bb2db3b57c0213fa
work_keys_str_mv AT ehrnthallerc alterationofcomplementhemolyticactivityindifferenttraumaandsepsismodels
AT amarau alterationofcomplementhemolyticactivityindifferenttraumaandsepsismodels
AT weckbachs alterationofcomplementhemolyticactivityindifferenttraumaandsepsismodels
AT kalbitzm alterationofcomplementhemolyticactivityindifferenttraumaandsepsismodels
AT huberlangm alterationofcomplementhemolyticactivityindifferenttraumaandsepsismodels
AT bahramis alterationofcomplementhemolyticactivityindifferenttraumaandsepsismodels
_version_ 1718403074022703104